Femasys Company Insiders
| FEMY Stock | USD 0.51 0.003 0.59% |
Femasys employs about 69 people. Reviewing how management performs at Femasys provides context around adaptability, decision quality, and the consistency of business execution. The practical question is whether leadership is creating repeatable business progress instead of simply managing the narrative around the company.
Management Team Effectiveness
The company has return on total asset (ROA) of -69.37 % which implies that it generated a $69.37 loss per $100 of asset base. This is below the acceptable range for the industry. Similarly, it shows a return on stockholder's equity (ROE) of -376.23 %, which indicates that the return on shareholder capital is below zero.As of last week, Common Stock Shares Outstanding is anticipated to decline to approximately 15.5 M. In addition to that, Net Loss is anticipated to decline to approximately -10.8 M.
Stock Institutional Investors
Institutions hold about 10.59% of shares while insiders own roughly 9.58%. Annual revenue is about 1.63 Million. How the institutional base reacts to earnings changes can move Femasys in the short term. Shares outstanding are near 59.5 M. Whether the institutional base is growing or shrinking quarter over quarter matters more than the current snapshot.
| Shares | Hrt Financial Llc | 2025-12-31 | 52.8 K | Advisor Group Holdings, Inc. | 2025-12-31 | 47.1 K | Nwf Advisory Services Inc | 2025-12-31 | 47.1 K | Kovack Advisors Inc | 2025-12-31 | 46.8 K | Bay Rivers Group | 2025-12-31 | 33.3 K | Two Sigma Securities, Llc | 2025-12-31 | 31.2 K | Sontag Advisory Llc | 2025-12-31 | 28.1 K | Two Sigma Investments Llc | 2025-12-31 | 26.1 K | Ocean Capital Management, Llc | 2025-12-31 | 25.3 K | Dauntless Investment Group, Llc | 2025-12-31 | 5.9 M | Vanguard Group Inc | 2025-12-31 | 1.4 M |
Insider Trading Activities
Insider activity around Femasys matters because officers and directors often act on business changes before the market catches up. The goal is to tell routine pay-related sales apart from trades that reflect genuine conviction.
Outstanding Bonds
Reviewing Femasys bond obligations provides context for understanding how much of the business is financed with fixed-income capital rather than purely with equity. Current market capitalization is about 31.15 Million. Bond investors and equity investors often care about the same cash flows, but they rank the risks differently.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Shares in Circulation | First Issued 2020-03-31 | Previous Quarter 28.9 M | Current Value 28.9 M | Average Shares Outstanding 15.8 M | Quarterly Volatility 6.6 M |
Macro event markers
Holders Distribution
Institutional ownership analysis for Femasys matters because banks, hedge funds, pension plans, and other professional investors can influence price and liquidity more forcefully than smaller holders. This matters because getting in early on a sponsorship cycle may help, but getting caught near a large-holder exit can have the opposite effect.
Market Cap and Value
Workforce Comparison
Femasys is rated third in number of employees among leading competitors. The total workforce of Health Care industry is currently estimated at about 861. Femasys holds roughly 69.0 in number of employees claiming about 8% of equities under Health Care sector.
Insider Trading History
The insider timeline for Femasys shows how management behavior has tracked against the stock's price over time. Investors focus on trades outside normal pay timelines, as those are more likely to reflect genuine conviction.
Notable Stakeholders
Reviewing the stakeholders around Femasys can help investors understand which people or institutions may influence direction, governance, and strategic pressure. The practical value is that investors can see where interests align, where they conflict, and how that tension could influence execution.
| Kathy LeeSepsick | President, Founder | Profile | |
| Kathy MBA | President Founder | Profile | |
| Daniel Currie | Senior COO | Profile | |
| Steven Damon | VP Devel | Profile | |
| James MD | Chief Officer | Profile | |
| Richard Spector | Chief Officer | Profile | |
| Kelley Nicholas | Chief Officer | Profile | |
| Christine Thomas | Senior Affairs | Profile | |
| Dov Elefant | Chief Officer | Profile | |
| Todd MBA | Chief Advisor | Profile | |
| MS MD | Chief Advisor | Profile | |
| Benjamin Dings | Vice Sales | Profile | |
| Edward MD | Chief Officer | Profile | |
| Mary JD | Vice Property | Profile | |
| Sue Owens | Vice Sales | Profile | |
| Naomi Phaneuf | Vice Marketing | Profile |
Management Information & Data Sources
Femasys is a micro-cap company across Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care. Management effectiveness is reflected in operating results, capital allocation choices, and margin durability. Operating follow-through relative to stated targets helps calibrate management credibility. Femasys employs 69 people.
Reported values for Femasys are derived from periodic company reporting and market reference feeds and then standardized for analysis. Refresh timing depends on source availability. Insider and management fields are mapped from published filings and company disclosures.
This content is curated and reviewed by:
Rifka Kats - Member of Macroaxis Editorial BoardWorkforce Efficiency and Productivity
Workforce metrics tied to Femasys offer a useful way to test whether headcount and economic output are moving in a productive direction. A disciplined workforce review can reveal whether execution quality is improving beneath the top-line numbers.
Femasys Manpower Efficiency
Return on Femasys Manpower
| Revenue Per Employee | 23.6K | |
| Revenue Per Executive | 101.8K | |
| Net Loss Per Employee | 272.7K | |
| Net Loss Per Executive | 1.2M |
Popular Tools for Femasys Stock analysis
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stocks Directory Find actively traded stocks across global markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |